A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers
Clinical trial NCT06978244 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06978244
- Sponsor
- Bausch & Lomb Incorporated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-29
- Primary completion
- 2026-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.